Colorectal cancer does not always happen by chance. In some families, inherited genetic changes can increase the likelihood of developing colorectal, endometrial and other cancers. This is known as hereditary colorectal cancer, and recognizing it can help families understand their cancer risk and make informed decisions about screening.
Lynch syndrome is one of the most common hereditary colorectal cancer syndromes. Genetic testing can help identify people who carry an inherited change associated with Lynch syndrome and other hereditary cancer conditions. However, genetic testing is not the only part of the assessment. Personal cancer history, family history and, when available, tumour testing can all provide important clues.
At Gutcare Clinics in Bangalore, people concerned about a personal or family history of colorectal cancer can discuss their risk with a specialist and understand whether further evaluation may be appropriate.
Have you or a close relative been diagnosed with colorectal cancer at a young age?
Speak with a specialist at Gutcare Clinics in Bangalore
What Is Hereditary Colorectal Cancer?
Hereditary colorectal cancer refers to colorectal cancer that occurs because a person has inherited a genetic change that increases their risk of developing cancer.
These inherited changes can affect genes involved in DNA repair, cell growth or other processes that normally help prevent abnormal cells from becoming cancerous.
Hereditary colorectal cancer accounts for a minority of all colorectal cancer cases, but identifying it is important because the implications can extend beyond the individual patient.
A person with an inherited cancer-predisposition variant may:
- Have a higher risk of colorectal cancer.
- Develop colorectal cancer at a younger age.
- Develop more than one primary cancer during their lifetime.
- Have relatives who also developed certain cancers.
- Need a different or more intensive cancer surveillance plan.
- Have relatives who may benefit from genetic counselling and testing.
Not every person with a family history of colorectal cancer has a hereditary syndrome. Family history can also be influenced by shared environmental factors, lifestyle, chance and the age at which relatives developed cancer.
What Is Lynch Syndrome?
Lynch syndrome is an inherited condition that increases the risk of colorectal cancer and several other cancers.
It is usually associated with pathogenic variants in mismatch repair genes such as MLH1, MSH2, MSH6 and PMS2. Changes involving EPCAM can also affect MSH2 function and lead to Lynch syndrome.
Mismatch repair genes help correct errors that occur when DNA is copied. When this repair system is impaired, DNA changes can accumulate and contribute to cancer development.
Lynch syndrome is particularly associated with:
- Colorectal cancer
- Endometrial cancer
- Ovarian cancer
- Stomach cancer
- Small bowel cancer
- Certain urinary tract cancers
- Some other cancers
Having Lynch syndrome does not mean that cancer is inevitable. It means the person’s inherited risk is higher, which is why appropriate surveillance and risk management are important.
Who Should Consider Genetic Testing for Hereditary Colorectal Cancer?
There is no single family-history pattern that identifies every person with hereditary colorectal cancer. Doctors consider several factors together.
People diagnosed with colorectal cancer at a younger age
Colorectal cancer diagnosed at a relatively young age can be a reason to investigate hereditary cancer risk.
Age alone does not prove that cancer is hereditary, but younger age at diagnosis can increase the importance of genetic evaluation.
People with abnormal tumour testing
Many colorectal cancers undergo testing for mismatch repair deficiency using immunohistochemistry (IHC) or microsatellite instability (MSI) testing.
A tumour showing mismatch repair deficiency or MSI-high characteristics may require further evaluation for Lynch syndrome.
However, an abnormal tumour test does not automatically mean the person has an inherited mutation. Some colorectal tumours develop these changes for non-hereditary reasons.
People with multiple cancers
A person who has developed colorectal cancer and another Lynch-associated cancer may warrant genetic evaluation.
The timing of the cancers and their specific types are important when assessing hereditary risk.
People with a known Lynch syndrome variant in the family
If a close relative has already been found to carry a pathogenic variant associated with Lynch syndrome, other family members may benefit from genetic counselling.
Testing can sometimes be directed specifically at the known family variant rather than starting with a broad panel.
People with a strong family history
A pattern involving several relatives with colorectal cancer or other Lynch-associated cancers can raise suspicion.
Doctors may look for:
- Several affected relatives.
- Cancer occurring across more than one generation.
- Colorectal or endometrial cancer at younger ages.
- More than one Lynch-associated cancer in the same person.
- A known hereditary cancer diagnosis within the family.
It is useful to document the cancer type and approximate age at diagnosis for affected relatives on both sides of the family.
Is Family History Enough to Diagnose Hereditary Colorectal Cancer?
No.
Family history can raise suspicion, but it cannot confirm a hereditary colorectal cancer syndrome.
For example, having one older relative with colorectal cancer does not necessarily mean that the family carries an inherited cancer-causing variant.
Conversely, a lack of an obvious family history does not always rule out hereditary cancer. Families may be small, relatives may have incomplete medical records, or some inherited conditions may show different cancer patterns between generations.
This is why genetic risk assessment considers the complete clinical picture rather than relying on one factor.
What Is MMR and MSI Testing?
Two terms frequently appear when discussing Lynch syndrome: MMR and MSI.
MMR stands for mismatch repair. IHC testing can examine whether specific mismatch repair proteins are present in tumour tissue.
MSI stands for microsatellite instability. MSI testing looks for changes in repetitive sections of DNA that can occur when the mismatch repair system is not functioning normally.
Both tests examine the tumour, rather than directly proving that an inherited mutation is present.
If tumour testing suggests mismatch repair deficiency, additional evaluation may be recommended to determine whether Lynch syndrome is responsible.
Tumour Testing vs Genetic Testing: What Is the Difference?
These tests have different purposes.
Tumour testing examines cancer tissue to look for features associated with mismatch repair deficiency or microsatellite instability.
Germline genetic testing examines DNA from a blood or saliva sample to look for an inherited genetic variant that is present throughout the person’s body.
A simplified pathway may look like this:
Colorectal cancer or concerning family history → clinical assessment → tumour testing when appropriate → genetic counselling → germline genetic testing when indicated → personalised surveillance
The exact sequence can vary depending on the patient’s circumstances and the tests already performed.
What Happens During Genetic Counselling?
Genetic counselling helps a person understand why testing is being considered and what different results could mean.
A consultation may cover:
- Personal cancer history.
- Family cancer history.
- Previous pathology reports.
- Tumour test results.
- Possible hereditary cancer syndromes.
- Benefits and limitations of genetic testing.
- Potential implications for family members.
- Appropriate screening and follow-up.
This discussion is important because genetic reports are not always simply “positive” or “negative”.
What Do Genetic Test Results Mean?
Genetic testing can produce several types of results.
Pathogenic or likely pathogenic variant
A pathogenic or likely pathogenic variant can indicate an inherited cancer-predisposition condition when interpreted in the appropriate clinical context.
The result may lead to a personalised surveillance plan and discussion of testing for eligible relatives.
Negative result
A negative test means that no clinically significant variant was identified in the genes included in the test.
However, a negative result does not necessarily eliminate hereditary risk in every situation. If the family history remains strongly concerning, a doctor may recommend continued risk-based screening or further evaluation.
Variant of uncertain significance
A variant of uncertain significance (VUS) is a genetic change for which there is not enough evidence to determine whether it is harmful.
A VUS should not automatically be treated as a diagnosis of Lynch syndrome or another hereditary cancer syndrome.
What Happens If Lynch Syndrome Is Confirmed?
A confirmed Lynch syndrome diagnosis can change how a person approaches cancer surveillance.
The exact plan depends on factors such as the specific gene involved, age, personal medical history and family history.
Management may include:
- More frequent colorectal surveillance.
- Discussion of screening for other Lynch-associated cancers.
- Appropriate evaluation of symptoms.
- Genetic counselling for family members.
- Coordination between relevant specialists.
Importantly, surveillance recommendations are not identical for every Lynch syndrome gene. A personalised plan is preferable to applying the same screening schedule to everyone.
If you have received an abnormal MSI or MMR result, or have a strong family history of colorectal cancer, consider discussing the result with a specialist rather than interpreting it independently.
When Should You Talk to a Doctor About Hereditary Colorectal Cancer?
Consider discussing hereditary cancer risk if:
- You were diagnosed with colorectal cancer at a young age.
- A close relative developed colorectal cancer at a young age.
- Several relatives have colorectal or related cancers.
- You have had more than one type of cancer associated with Lynch syndrome.
- A pathology report mentions MSI-high or mismatch repair deficiency.
- A relative has a confirmed Lynch syndrome pathogenic variant.
- You are concerned about a repeated pattern of colorectal or endometrial cancer in your family.
You do not need to wait until multiple family members develop cancer before asking about hereditary risk.
If you are in Bangalore, GutCare Clinics can help you discuss your personal and family history and understand whether further specialist evaluation may be appropriate.
Key Takeaway
Hereditary colorectal cancer is important to recognise because an inherited cancer risk can affect both the individual and their relatives.
Lynch syndrome is a major hereditary colorectal cancer syndrome and can be associated with changes in mismatch repair genes. Young-onset colorectal cancer, abnormal MMR or MSI tumour testing, multiple Lynch-associated cancers and a concerning family history can all be reasons to consider genetic evaluation.
Tumour testing and germline genetic testing answer different questions, while genetic counselling helps put the results into context.
If you have concerns about your family history or your own colorectal cancer risk, discussing them with a specialist can help determine the appropriate next step.
Looking for specialist guidance on hereditary colorectal cancer in Bangalore?
Find us here:Gutcare Clinics, Indiranagar, Bangalore | Dr. Yuvraj Singh Gehlot, Digestive Health Specialist
Frequently Asked Questions About Hereditary Colorectal Cancer
What is hereditary colorectal cancer?
Hereditary colorectal cancer is colorectal cancer associated with an inherited genetic change that increases a person’s risk of developing cancer. Lynch syndrome is one of the major hereditary colorectal cancer syndromes.
Who should get genetic testing for hereditary colorectal cancer?
People with young-onset colorectal cancer, abnormal MMR or MSI tumour results, multiple Lynch-associated cancers, a known familial genetic variant or a concerning family history may benefit from genetic evaluation.
Can colorectal cancer be hereditary even without a family history?
Yes. The absence of a known family history does not completely rule out an inherited cancer syndrome. Family size, incomplete medical records and differences in how hereditary conditions appear can make family patterns difficult to recognise.
Is Lynch syndrome the same as hereditary colorectal cancer?
No. Hereditary colorectal cancer is a broader term covering colorectal cancer caused by inherited genetic conditions. Lynch syndrome is one important hereditary colorectal cancer syndrome.
What is the difference between MSI and MMR testing?
MMR testing, commonly performed using IHC, examines mismatch repair proteins in tumour tissue. MSI testing looks for microsatellite instability in tumour DNA. Both can help identify tumours that may need further evaluation for Lynch syndrome.
Does a positive genetic test mean I will definitely develop colorectal cancer?
No. A pathogenic inherited variant can increase cancer risk, but it does not mean that cancer is certain to occur. Risk management and surveillance depend on the specific condition and individual circumstances.
Should family members be tested if Lynch syndrome is found?
Family members may benefit from genetic counselling and, where appropriate, testing. When a specific familial pathogenic variant is known, testing can often focus on that variant.
Is genetic counselling necessary before genetic testing?
Genetic counselling can help explain why testing is being considered, what different results may mean and how findings could affect screening and family members. The exact process can vary by clinical setting.
